CD95L pro-drug: a novel Swiss Army Knife in cancer therapy?
- 2007-02-16
Published in:
- Cell death and differentiation. - 2007
Antigens, Neoplasm
Apoptosis
Drug Design
Fas Ligand Protein
Humans
Immunity, Cellular
Neoplasms
Peptide Hydrolases
T-Lymphocytes
fas Receptor
- Language
-
- English
- Open access status
- green
- Identifiers
-
- DOI 10.1038/sj.cdd.4402069
- PMID 17301839
- Persistent URL
- https://sonar.ch/global/documents/6771
Statistics
Document views: 26
File downloads:
- Full-text: 0